Combination drug therapy against OAB normalizes micturition parameters and increases the release of nitric oxide during chemically induced cystitis

Today, monotherapy is the most common pharmacological treatment option for patients suffering from overactive bladder (OAB). Recent reports have indicated potential benefits of combination therapy, using a muscarinic antagonist and a β(3)‐adrenoceptor agonist. This may be of particular interest for...

Descripción completa

Detalles Bibliográficos
Autores principales: Patel, Bhavik, Perez, Fernando, Aronsson, Patrik, Alothmani, Ranya, Carlsson, Thomas, Winder, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7005531/
https://www.ncbi.nlm.nih.gov/pubmed/32030913
http://dx.doi.org/10.1002/prp2.564

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7005531/
https://www.ncbi.nlm.nih.gov/pubmed/32030913
http://dx.doi.org/10.1002/prp2.564

Ejemplares similares